ArticleJournal of cardiothoracic surgery2026
Post-operative volume changes in residual lung lobes after VATS pulmonary segmentectomy for early stage non-small cell lung cancer.
Article in Journal of cardiothoracic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- AI-Assisted Volumetric Comparison of Parenchyma-Sparing Effect in Robotic Segmentectomy vs Lobectomy.JSLS : Journal of the Society of Laparoendoscopic SurgeonsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary segmentectomy is a valid alternative to lobectomy in early-stage non-small cell lung cancer (NSCLC). However, limited data are available on post-operative compensatory volume changes following segmentectomy. The aim was to clarify the temporal patterns of lobar volume changes in the residual and contralateral lung at 6 and 12 months post-segmentectomy using 3D reconstruction.
methodsWe retrospectively reviewed patients who underwent video-assisted thoracoscopic surgery (VATS) segmentectomy for early-stage NSCLC from 2017 to 2022. Pre-operative lung lobe volumes were calculated from three dimensional (3D) reconstruction (Materialize
resultsA total of 30 patients (median age: 66, sex ratio M/F: 14/16) were included. On the right side (n = 15), median lobar volume loss reached 62.4% (p = 0.03) after upper S1 segmentectomy, 38.9% (p > 0.05) after S2 and 35.5% (p > 0.05) after S6 at 12 months. Compensatory expansion was predominant in the lower lobe for upper segmentectomies, respectively + 24.2% (p > 0.05) for S1 and + 22.2 (p > 0.05) for S2, whereas compensation in middle lobe was present for S1 segmentectomy (+ 17%, p = 0.03) and for S6 (+ 14.9%, p > 0.05). On the left side, median volume loss was 73.0% (p = 0.03) after upper trisegmentectomy, 34.8% (p > 0.05) after lingulectomy, and 37.4% (p = 0.03) after S6 resection. Compensatory expansion mainly involved the lower lobe for upper resections (+ 31.4%, p = 0.03), while the upper lobe increased by + 11.4% (p = 0.03) following lower-lobe segmentectomy. No volume difference was observed in the contralateral lobes over 12 months across resection types. Overall total lung volume was largely unchanged at 12 months across resection types, except for left S6 segmentectomy (a 6.6% decrease, p = 0.03).
conclusionVolume compensation mechanisms occur after VATS segmentectomy, with more pronounced volume reduction following upper-lobe resections compared to lower-lobe resections. The absence of contralateral volumetric compensation may allow subsequent compensatory responses to occur and potentially contribute to a better preservation of lung function in patients undergoing additional pulmonary resections. Characterizing these patterns is important for surgical planning and optimizing postoperative management in patients undergoing segmentectomy for early-stage NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.